Brokerages Set Axsome Therapeutics, Inc. (NASDAQ:AXSM) PT at $167.64
Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) have received an average rating of “Buy” from the fifteen analysts that are currently covering the company, Marketbeat reports. Fifteen equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have covered the stock in the […]
Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) have received an average rating of “Buy” from the fifteen analysts that are currently covering the company, Marketbeat reports. Fifteen equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have covered the stock in the […]
